Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-09-14

Clinical Trial Update: Bepotastine Besilate-corticosteroid Nasal Spray Combination Compared to Placebo, Bepotastine Besilate Nasal Spray, and Corticosteroid Nasal Spray in the Treatment of Patients With Seasonal Allergic Rhinitis [Phase 2]

View source ↗

Summary

Phase 2 trial comparing a Bepotastine Besilate-corticosteroid nasal spray combination to individual components and placebo for seasonal allergic rhinitis; study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bepotastine besilate nasal spray (bepotastine besilate nasal spray)
  • Bepotastine besilate-corticosteroid nasal spray combination (bepotastine besilate-corticosteroid nasal spray combination)
  • Corticosteroid nasal spray (corticosteroid nasal spray)

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Seasonal Allergic Rhinitis | Phase 2 | Status: COMPLETED | Results posted: 2020-09-14